Pembrolizumab with etoposide and a platinum-based compound for untreated extensive-stage small-cell lung cancer [ID1509]
Discontinued
Reference number: GID-TA10413
As you will be aware, the Department for Health and Social Care has asked NICE to conduct an appraisal of pembrolizumab with chemotherapy for untreated extensive-stage small-cell lung cancer.
Following an update from the company further information on the timelines for this appraisal will be available in due course.